Related Experiment Video
Updated: Jun 26, 2025

Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
Published on: August 18, 2022
Cost-of-Illness of Skin Cancer: A Systematic Review
Annick Meertens1,2,3, Laura Van Coile1,2, Tijs Van Iseghem3
1Department of Dermatology, University Hospital Ghent, Corneel Heymanslaan 10, 9000, Ghent, Belgium.
Understanding the economic impact of skin cancer is crucial due to its rising incidence. This review highlights the need for standardized cost-of-illness studies to identify key cost drivers for melanoma and keratinocyte carcinoma.
Area of Science:
- Oncology
- Health Economics
- Public Health
Background:
- Rising incidence of skin cancer necessitates understanding its economic burden.
- Current cost-of-illness studies for skin cancer are fragmented due to diverse methodologies.
- Lack of standardized approaches hinders comprehensive economic impact assessment.
Purpose of the Study:
- Systematically review cost-of-illness studies for melanoma and keratinocyte carcinoma.
- Provide an overview of methodological approaches used in these studies.
- Identify the primary cost drivers associated with skin cancer treatment.
Main Methods:
- Systematic review adhering to 2020 PRISMA guidelines.
- Searched PubMed, Embase, and Web of Science (Dec 2022-Dec 2023).
- Included 45 studies published after 2012, assessing methodological quality.
Main Results:
- 45 studies evaluated over 500,000 patients; 36 focused on melanoma.
- Direct costs were in all studies; indirect costs in only nine.
- Heterogeneity in study populations, methods, and healthcare systems observed.
- Melanoma costs increased with tumor stage; systemic therapy was a key driver in advanced stages.
- No clear cost drivers identified for keratinocyte carcinoma.
Conclusions:
- A standardized study design for skin cancer cost-of-illness research is needed.
- Enhanced comparability and identification of cost drivers will improve decision-making.
- Evidence-based strategies can be developed for effective skin cancer management.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Cancer Survival Analysis
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Burn Injuries
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Cancer Prevention
Some...

